# Lane Zhao

> Lane Zhao is a Series B investor at InnoVision Capital backing GreenTech and Life Science. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [InnoVision Capital](https://shizune.co/investors/profile/china-innovision-capital)
- Location: Beijing, China
- Total investments: 2
- Last investment: Oct 2022
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/lane-zhao

Lane Zhao is a Series B investor at InnoVision Capital in Beijing focused on GreenTech and Life Science. Lane F. Zhao (Beijing) joined KKR in 2005, as one of the first team members in KKR Asia at the time. At KKR, Mr. Zhao has played a significant role in the investments in Far East Horizon, United Envirotech, Rundong Auto, Sino Ocean, CICC, VATS Liquor Store, Modern Dairy and Yageo Electronics. Currently, he is on the board of directors of RundongAuto, United Envirotech and Sino Ocean. Prior to joining KKR, he was with Morgan Stanley Private Equity Asia, where he was significantly involved in a number of successful and innovative private equity transactions in China, including Mengniu Dairy, Belle International, Ping An Insurance and Paradise Retail. He holds a B.S. in Physics, with first class honors, from Tsinghua University in China.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| GreenTech | 1 | 50% |
| Life Science | 1 | 50% |
| Biotechnology | 1 | 50% |
| Environmental Engineering | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Debt Financing | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Leader Environmental Technologies | Leader Environmental Technologies focuses on sludge treatment, smart water and energy management, and greentech investments. | $15M | Debt Financing | Oct 12, 2022 |  |
| Neurophth Therapeutics | Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally. | $61.9M | Series B | Feb 09, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Grand Mount Capital](https://shizune.co/investors/profile/grand-mount-capital) — VC Fund, 1 deal together
- [Guofang Capital](https://shizune.co/investors/profile/guofang-capital) — VC Fund, 1 deal together
- [Harvest Capital](https://shizune.co/investors/profile/harvest-capital) — VC Fund, 1 deal together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 1 deal together
- [Northern Light Venture Capital](https://shizune.co/investors/profile/northern-light-venture-capital) — VC Fund, 1 deal together
- [Oriza Holdings](https://shizune.co/investors/profile/oriza-holdings) — VC Fund, 1 deal together

## About InnoVision Capital

VC Fund · Beijing, China

InnoVision Capital, founded by former KKR & Co. executives, is a Greater China focused private equity firm.

1 contacts available at InnoVision Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Lane Zhao | Founder, CEO | https://shizune.co/investors/profile/lane-zhao |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Lane Zhao invest in?

Lane Zhao invests primarily in GreenTech, Life Science and Biotechnology startups, most often at Series B and Debt Financing stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Lane Zhao last invest?

The most recent investment recorded for Lane Zhao closed in Oct 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co